INTRODUCTION
The Rab family of proteins consists of more than 40 Ras-related GTPases, each involved in specific steps of vesicular transport (1-3). Rab1A and Rab1B are two of the most extensively studied members of the Rab family. Both proteins are found in membranes of the ER 1 
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Prenylation of Rab proteins is catalyzed by geranylgeranyltransferase type II (GGTase II) (17, 18) . GGTase II will prenylate the target cysteine residues only if the nascent Rab substrate is first bound to a carrier protein termed Rab Escort Protein (REP) (19, 20) . REP initially binds to the Rab protein while it is in the GDP-bound state (21) . After the prenyl groups are added to the carboxyl terminus of the Rab protein, GGTase II is released, while REP remains bound to the prenylated protein and delivers it to the membrane. Chavrier et al. (22) have used chimeric proteins to show that the hypervariable domain near the carboxyl-terminus of each Rab GTPase protein contains information required for targeting to a specific subcellular membrane compartment. However, the precise role of the chaperone (i.e., REP) in this process has yet to be defined. One possibility is that REP acts cooperatively with the Rab protein to promote association with a specific docking complex at the target membrane. An alternative possibility is that REP is a "passive" carrier that does not interact directly with putative Rab docking complexes at the acceptor membrane.
In the present study we explore the role of REP in the membrane targeting of Rab1B, taking advantage of our previous observations that amino acid substitutions within the Rab1B α2-helix (e.g., Y78→D) completely prevent association with REP (23) . By changing the two carboxyl-terminal cysteine residues of Rab1B(Y78D) to a CLLL motif, we were able to convert the protein to a substrate for geranylgeranyl transferase type I (GGTase I), which can modify monomeric GTPases in the absence of REP. Despite its inability to associate with REP or GDI, the Rab1B(Y78D)CLLL construct was delivered to ER membranes. However, when a dominant-negative mutation was introduced into the same protein, it failed to suppress ER →Golgi transport. Thus, although membrane targeting of Rab1B can occur in the absence of REP, it appears that protein interactions mediated either directly by the Rab1B α2 helical domain After 18 h the cells were harvested and lysed as described in the preceding section. One tenth of the cell lysate was subjected to SDS-PAGE and immunoblot analysis to confirm MycRab1B expression. The Myc-tagged Rab proteins were immunoprecipitated from the remaining cell lysate as described above. After SDS-PAGE and fluorography, the dried gel was cut into 0.5 cm sections and the amount of Interaction of Rab Proteins with FLAG-GDIα in Intact Cells. HEK293 cells were co-transfected with a pCMV vector encoding FLAG-tagged GDIα and the specified Myc-tagged Rab1B.
Twenty four hours after transfection, cells from a 100 mm culture were harvested and soluble fractions were prepared as described (26) . One tenth of this fraction was subjected to SDS-PAGE and immunoblot analysis to check for expression of FLAG-GDI and MycRab1B. The remaining sample was subjected to immunoprecipitation with anti-FLAG affinity beads to detect Rab proteins bound to FLAG-GDIα, as described in detail by Wilson et al. (26) . were harvested immediately after the pulse, or after the 2-h chase, and the radiolabeled LDL receptor was immunoprecipitated as described by Castellano et al. (32) .
Immunofluorescent Localization of Expressed Rab Proteins in 293 Cells

RESULTS
A REP-Binding-Deficient Rab1B Mutant Can be Prenylated After Changing the Carboxyl-
Terminal Motif -Mutations in the predicted α2 helix in the Switch-2 domain of Rab1B (e.g., Y78 → D) disrupt the ability of the GTPase to interact with REP, without impairing GTP binding or hydrolysis (23) . Consequently the same mutations prevent REP-dependent prenylation of Rab proteins by GGTase II (23, 33) . We hypothesized that an α2 helix mutant might be used to determine whether or not REP is required for the delivery of Rab1B to intracellular membranes, provided that the GTPase could be prenylated by an alternate REPindependent mechanism. To achieve this goal, we took advantage of our previous finding that Rab8, which ends with a C-terminal CAAL geranylgeranyl transferase type I (GGTase I) which does not require the formation of a REP/Rab complex (33) . Hence, the two C-terminal cysteine residues of Rab1B(wt) and Rab1B(Y78D)
were replaced with CLLL to form a GGTase I recognition motif (34, 35) . Cell-free assays were used to compare the prenylation of the various recombinant Rab1B proteins by GGTase I versus GGTase II. As seen in Fig. 1 , Rab1B(wt), which ends with a CC motif, is a substrate only for GGTase II. Addition of the CLLL motif to the C-terminus of this protein permits it to be prenylated by either GGTase I or GGTase II. Separate studies in which REP was omitted from the reaction mixture showed that prenylation of Rab1B(wt) or Rab1BCLLL by GGTase II was entirely dependent on the presence of the escort protein (data not shown). On the other hand, addition of REP to the GGTase I reaction neither permitted prenylation of Rab1B(wt), nor enhanced prenylation of Rab1B(CLLL) by GGTase I (data not shown). Most importantly, the studies in Fig. 1 show that by substituting the normal CC motif with CLLL, the REP-bindingdeficient Rab1B(Y78D) mutant could be prenylated in a REP-independent manner by GGTase I.
To verify that the results of the cell-free assays accurately predicted the ability of the C- Mevalonate is an isoprenoid precursor that is incorporated into the geranylgeranyl pyrophosphate substrate used by either GGTase I or GGTase II. Incorporation of this precursor was measured in the presence and absence of GGTI-298, a specific inhibitor of GGTase I (29) . Several general conclusions can be drawn from the results. First, when both GGTase I and GGTase II were active (no inhibitor), Rab1B(Y78D) with the normal CC motif was not labeled by [ prenylation of Rab1B(Y78D)CLLL was completely prevented by the inhibitor, GGTI-298.
Taken together, these results confirm that the modification of Rab1B(Y78D)CLLL in vivo is catalyzed by GGTase I, as indicated by the cell-free assay (Fig. 1) . Surprisingly, the wild-type Rab1B(CLLL), which has only a single cysteine available for modification, showed a greater incorporation of [ 3 H]Mev per unit protein than the wild-type Rab1B with the original CC motif.
However, it is important to bear in mind that this type of study does not provide a stoichiometric analysis of prenylation, because overexpression results in the accumulation of a large pool of non-prenylated Rab1B in the transfected cells (26) . Thus, the increased incorporation of [ 3 H]Mev into Rab1B(CLLL), compared to Rab1B, may reflect the fact that two different GGTase enzyme systems are able to prenylate the Rab1B(CLLL), whereas only the REP/GGTaseII system can prenylate Rab1B with the CC ending.
Addition of a CLLL Motif to the C-terminus of Rab1B Does not Affect the Interaction with REP.
The absence of prenylation of Rab1B(Y78D)CLLL by REP/GGTase II in the cell-free assay ( Fig. 1) suggested that the addition of CLLL motif to the Y78D mutant allowed prenylation by GGTase I but did not restore REP binding. This was confirmed in intact cells where the CLLLversions of Myc-tagged Rab1B wt or Y78D were co-expressed with T7-tagged REP1. As shown in Fig. 3 , size-exclusion chromatography of cytosol obtained from cells expressing MycRab1B-CLLL revealed a typical high molecular weight Rab/REP complex, similar to that previously reported for MycRab1B(wt) (23) . In contrast, MycRab1B(Y78D)-CLLL was unable to form a stable complex with T7-REP1, consistent with our earlier observations with
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The Y78D mutation prevents interaction of Rab1B with GDI. Sequence alignments of REP and GDI reveal four major conserved regions between these two proteins (36), consistent with some functional similarities. Both proteins associate with prenylated Rab proteins in the GDP-bound conformation and can deliver them to membranes (10, 23, 26, 37, 38) . However, GDI cannot replace REP in the prenylation reaction (38) . For the current studies, the possibility must be considered that GDI could associate with the nascent Rab1B(Y78D)CLLL after prenylation by GGTase I and serve as an escort protein in place of REP. To address this issue, we used an established co-immune precipitation assay (26, 39) to compare the abilities of the Myc-tagged Rab constructs to interact with FLAG-GDIα in transfected 293 cells. Fig. 4 shows that MycRab1B and MycRab1B-CLLL were effectively co-immunoprecipitated with FLAG-GDI, whereas the Y78D mutants, regardless of the C-terminal cysteine motif, were not associated with FLAG-GDI. These observations provide direct evidence that the Switch-2 region of Rab1B is important for interaction of the GTPase with GDI as well as with REP, implying that conserved regions in GDI and REP are involved in binding the α2 helix of the Rab protein. These findings are also important for the localization studies described in the following sections, because they indicate that any membrane targeting of Rab1B(Y78D)CLLL must occur by a mechanism that does not depend on REP or GDI serving as a carrier. (Figs. 1 & 2) . In contrast, MycRab1B(Y78D) was localized entirely in the cytosolic fraction, as expected in light of its inability to undergo REP-dependent prenylation. Most notably, addition of the CLLL motif to the C-terminus of Y78D allowed a significant portion of the expressed protein to localize to the membrane fraction (Fig. 5) . protein when an acceptor membrane is encountered. In the context of this model, we would expect to see an increased cytosolic pool of mono-prenylated Rab1B(CLLL) but not Rab1B(Y78D)CLLL, since the latter cannot interact with REP and is prenylated exclusively by GGTase I.
Immunofluorescent localization of Rab1B in intracellular membranes.
From the preceding observations we conclude that MycRab1B(Y78D)CLLL can associate with membranes after prenylation by GGTase I in intact cells. This apparently occurs through a mechanism that does not require the formation of a REP or GDI carrier complex. We next carried out a study using immunofluorescence microscopy to determine whether or not the CLLL-modified versions of Rab1B were delivered to the same subcellular compartments as the wild-type Rab1B. Cells expressing MycRab1B(wt) exhibited a juxta-nuclear staining pattern that showed significant overlap with proteins known to function in the Golgi compartment; i.e., GM130 (41) and Rab6 (42) (Fig. 7) . MycRab1B(wt) also showed partial co-localization with a resident ER protein, calreticulin (43) (Fig. 7) . This is typical of the localization reported for Rab1 in previous studies (5, 6, 26) .
In order to directly compare the localization of the MycRab1B-CLLL constructs with the localization of the wild-type protein in the same cells, we carried out a co-transfection study in which Rab1B(wt) was tagged with the HA epitope and the CLLL constructs were tagged with the Myc epitope. Preliminary studies were first performed in which cells were co-transfected with Rab1B(wt) constructs bearing the different epitope tags. These studies established that the localization pattern of Rab1B was not changed by the HA-epitope (not shown). The images in Fig.8 demonstrate that MycRab1B-CLLL (mono-prenylated but still competent to bind REP) had an immunofluorescent localization pattern nearly identical to that of HA-Rab1B(wt). The localization pattern of MycRab1B(Y78D)CLLL (mono-prenylated, but incompetent to bind REP) was similar to that of HA-Rab1B(wt), but also contained a peripheral component that extended beyond the perinuclear region in a pattern reminiscent of calreticulin. From these observations we can conclude that MycRab1B(wt), MycRab1B-CLLL and MycRab1B(Y78D)CLLL were all targeted to ER/Golgi membranes, although the latter construct must arrive in this compartment by a mechanism that is does not depend on REP or GDI escort functions.
MycRab1B-CLLL and MycRab1B(Y78D)CLLL undergo C-terminal proteolytic processing and carboxymethylation in HEK293 cells -Proteins modified by GGTase I typically undergo
additional modifications consisting of the removal of the three amino acids distal to the prenylated cysteine, followed by C-terminal carboxymethylation of the exposed prenyl cysteine residue (44) . The results shown in Fig. 9 , demonstrate that volatile
The Y78D mutation abrogates the activity of a dominant-negative Rab1B mutant. To determine whether the mono-prenylated Rab1B constructs bearing the CLLL motif and/or the Y78D substitution might interfere with ER → Golgi transport, we co-expressed these proteins together with the human low density lipoprotein receptor (LDLR) in 293 cells. The LDLR undergoes Oglycosylation in the medial Golgi compartment, resulting in a shift in its electrophoretic mobility on SDS gels, from a sharp band at approximately 120 kDa (the immature, ER form) to a poorly resolved band between 160-170 kDa (32, 49, 50) . As shown in Fig. 10 , when either Rab1B(wt), Rab1BCLLL, Rab1B(Y78D), or Rab1B(Y78D)CLLL was co-expressed with the LDLR, processing of the radiolabeled receptor to the mature O-glycosylated form was readily detected by pulse-chase analysis of the immunoprecipitated protein. Thus, the Y78D constructs do not impair the function of endogenous Rab1-dependent ER→Golgi transport pathways. Previous studies have shown that Rab proteins bearing amino acid substitutions at the position equivalent to S17 in H-Ras are locked in the inactive GDP state because they have a greatly reduced affinity for GTP but not GDP (6, 7, 51) . Introduction of such mutations into Rab1A (S25N) or Rab1B(S22N) causes these proteins to act as dominant suppressors of Rab1function in cultured cells, so that ER →Golgi protein trafficking is arrested (6) . To determine whether the monoprenylated form of Rab1B (S22N) would still be able to suppress ER → Golgi trafficking, we converted its C-terminus to the CLLL motif. As shown in Fig. 10 , the mono-prenylated Rab1B(S22N)CLLL suppressed LDLR processing just as well as the Rab1B(S22N) with the normal CC motif (Fig. 10) . However, when the Y78D mutation was inserted into the MycRab1B(Y78D)CLLL show similar localization (Fig. 8) , only the former construct suppresses ER→Golgi trafficking when the S22N substitution is introduced.
DISCUSSION
In the present study we have examined the requirement for REP in the membrane delivery of Rab1B in intact cells by using four different Myc-tagged Rab1B constructs: (i) Rab1B(wt) binds to REP and is di-geranylgeranylated exclusively by GGTase II. (ii) Rab1B(Y78D) cannot bind REP and therefore fails to undergo prenylation. (iii) Rab1B-CLLL binds to REP and is geranylgeranylated on the single cysteine by GGTase II, but it can also be modified in a REPindependent manner by GGTase I. (iv) Rab1B(Y78D)CLLL cannot bind REP, but can be geranylgeranylated by GGTase I. Our results show that whereas Rab1B(Y78D) partitioned exclusively in the cytosol, both Rab1B-CLLL and Rab1B(Y78D)CLLL accumulated in membrane fractions of transfected cells (Figs 5 & 6) . The subcellular distribution patterns of these proteins resembled that of the wild-type Rab1B (Figs. 7&8) . Moreover, they underwent additional modifications typical of CAAX-motif proteins (proteolytic removal of the terminal LLL tripeptide and carboxymethylation, Fig. 9 ) that require enzymes localized in the ER (48, 52) .
It is well established that under normal circumstances both REP and GDI function in the delivery of prenylated Rab proteins to intracellular membranes (38, 40, 53, 54) . However, since the Y78D mutation prevents Rab1B from binding to REP or GDI (Figs.3&4) (23) , we conclude that protein interactions mediated by these carrier proteins are not absolutely required for targeting of Rab1B to intracellular membranes, provided that C-terminus can be geranylgeranylated by an alternative mechanism (GGTase I).
It remains to be determined precisely how the mono-geranylgeranylated form of Rab1B(Y78D)CLLL is delivered to membranes in the absence of REP or GDI. However, it seems likely that the initial targeting of this protein to the ER may follow the same path as newly prenylated Ras and Rho GTPases. In this regard, the recent studies of Choy et al. (48) have suggested a model wherein the prenylated cysteine, in the context of the CAAX motif, may serve as a signal structure that targets proteins to a receptor on the ER membrane, so that AAXtrimming and carboxymethylation of different GTPases can be completed by a common set of enzymes. Proteins destined for peripheral membranes (e.g., Ras, RhoA, Rac1) are then sorted
by mechanisms yet to be defined (55) (7) and presumably involves competition with endogenous Rab1 for binding to nucleotide exchange factors or other docking proteins in the COPII complex on the budding transport vesicle (7, 57, 58) . Our results show that Rab1B(S22N)-CLLL is fully capable of suppressing ER→Golgi transport of the LDL receptor (Fig. 10) , implying that the relevant Rab1B(S22N) protein interactions can be supported by mono-geranylgeranylation and carboxymethylation instead of di-geranylgeranylation. However, when the Y78D mutation was introduced into Rab1B(S22N)-CLLL, its inhibitory effect on LDL receptor trafficking was lost.
There are two obvious possibilities that could account for the ability of the Y78D mutation to eliminate the inhibitory activity of Rab1B(S22N): The first is that REP (or GDI) plays a cooperative role with the Rab1 GTPase to promote its interaction with the COPII docking complex or nucleotide exchange factors at the vesicle membrane. According to this model, the Y78D mutation, by preventing Rab1B from associating with REP (23) or GDI (Fig. 4) helix of Rab5 is one of the domains that affects its localization and functional specificity (60) .
Thus, it will be interesting to determine how amino acid substitutions in the α2 helix of Rab1B may affects its ability to interact with components of the COPII complex. The functional evaluation of such Rab mutants has been hindered by the fact that they cannot be prenylated and delivered to membranes by the REP-dependent GGTaseII pathway. However, the present study demonstrates that this problem can by circumvented by changing the C-terminal motif to one that can be recognized by GGTase I. by guest on 
